NIPH Clinical Trials Search

Comparison of gastric and small-bowel transit time between Lubiprostone, and placebo-controlled in healthy volunteers : a double-blind, placebo-controlled study by capsule endoscopy

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	healthy volunteers
Date of first enrollment	2013/07/26
Target sample size	6
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	The group who takes Lubiprostone The group who takes Placebo

Outcome(s)

Primary Outcome	gastric and small-bowel transit time
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	20years-old
Age maximum	Not applicable
Gender	Male
Include criteria	Patient who fills everything the following 1) Patient of 20 years or more 2) Patient who gives written informed consent
Exclude criteria	The patient who collides with either the following assumes that it doesn't put it in to the examination 1) Drug allergy 2) Subjects with malignancy 3)Others